A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.
about
Copper containing intra-uterine devices versus depot progestogens for contraceptionCombination prevention: new hope for stopping the epidemicSystemic lupus erythematosus: strategies to improve pregnancy outcomesUnderstanding and Managing Pregnancy in Patients with LupusPreconception and contraceptive care for women living with HIVIntegrating prevention interventions for people living with HIV into care and treatment programs: a systematic review of the evidence.Linking sexual and reproductive health and HIV interventions: a systematic review.State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices.Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infectionSex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, ZambiaContraception for adolescents with lupus.Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate.Reliance on condoms for contraceptive protection among HIV care and treatment clients: a mixed methods study on contraceptive choice and motivation within a generalised epidemic.The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.Previous reproductive history and post-natal family planning among HIV-infected women in Ukraine.Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa.HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trialImproving sexual health for HIV patients by providing a combination of integrated public health and hospital care services; a one-group pre- and post test intervention comparison.The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Protocol-driven primary care and community linkages to improve population health in rural Zambia: the Better Health Outcomes through Mentoring and Assessment (BHOMA) projectContraception in HIV-positive female adolescents.Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraceptionSustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention ApproachesClinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research articleResponses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristicsAwareness and interest in intrauterine contraceptive device use among HIV-positive women in Cape Town, South Africa.Trends in contraceptive use among women with human immunodeficiency virusLiving with uncertainty: acting in the best interests of womenEffect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Differences in the Nonuse of any Contraception and Use of Specific Contraceptive Methods in HIV Positive and HIV Negative Rwandan Women.Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanismsEffect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.Providers' Perspectives on Provision of Family Planning to HIV-Positive Individuals in HIV Care in Nyanza Province, Kenya.Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.
P2860
Q24234768-8C4AE48E-D087-4D3E-A57D-105002610EECQ24630559-045F8BDE-7FFE-4146-A9F1-956A98CF69B4Q26741149-3AD81F57-5E46-41CA-8A87-E30F342223E9Q26798179-317137AD-6DC3-4657-AF3F-05F8AADA75F1Q27012918-2791985B-12FF-4A2A-969C-3E679B336680Q27313271-79A91B99-416B-4BC5-9F88-46900E708C38Q30495930-3908634C-8F85-4212-ABFD-4D96AAB6F8BAQ33540807-EBD6878B-D089-4530-AC92-EB247C5C3B71Q33575368-BCFE7ED4-7752-41D0-A8CC-5A63313B37DEQ33779655-D55BEC96-FDE2-457D-8718-A2FA80A072D7Q33795961-2DA70E8E-6A64-4D35-BB93-EEFD8ADB042BQ33804408-B280B4E2-3871-4B13-9BFD-F55812242E21Q33813399-FB408A69-3132-4C5F-B5B8-5A416C396A62Q33939641-2C5EA4EA-588C-42BA-81A0-E3BAB25018ECQ33956769-932AB3A8-7597-4882-9D0F-47F0BC39ACC4Q34023308-ACB7E18C-85C3-41AE-894E-DAB8CA21F317Q34071146-40C58898-8C5E-4730-BF91-957950E5CD07Q34129740-5FF65397-676F-44A6-84F0-D76F01B3236AQ34257078-67C05207-C8F7-4159-8CF9-C6038C303B9AQ34441040-905BB56F-96AA-4DD5-B503-DAB2F1C0DEC9Q34523865-775EA16D-C8E7-4DE8-927A-CB21B376D3C0Q34712821-78BA3401-D2FC-479E-A2AC-960C79C42AFEQ34790256-F035C112-E306-47CD-B8C6-ACEB94235736Q35068065-C05F2B97-633C-4EE1-97AD-47974259354FQ35140678-E110801F-912D-42CA-A1A6-3A664427121CQ35187981-E5D209A2-A73E-4B58-BCE4-C9DA31079EC6Q35208014-645D0036-0C4B-4497-BC42-D2D9F2BE58EDQ35602771-0EBE537E-E6BA-4910-8F5B-FE1F37073907Q35623071-981E0198-C9E1-42FB-A019-9AD47D6F17CBQ35903676-89556857-8437-40D2-AB01-F76DDC931E7DQ36072828-E787B749-B06E-4262-8813-13C46B632E87Q36253393-D03E1D3F-7515-4ABA-83B5-DEB7CC8EE9D5Q36410468-E6FE568B-5A87-4AD0-B6F5-460631BDDB74Q36460017-F8D10E48-23AB-46DF-B373-B2026D5808D2Q36497731-E30A5177-7E52-450C-AF74-542588B0C672Q36628484-5A951827-9366-4091-B8B6-D0E281AB6A70Q36651855-DCBD1623-5216-4907-A723-08D087C3E25AQ36860605-8EB51199-852F-44A7-90DF-80BAE0981D2FQ36980204-3E331947-5483-45AB-B44A-681C0B0450EAQ36984167-1FBA4173-C36E-47E7-9972-8E5F8911965B
P2860
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized trial of the intr ...... human immunodeficiency virus.
@en
A randomized trial of the intr ...... human immunodeficiency virus.
@nl
type
label
A randomized trial of the intr ...... human immunodeficiency virus.
@en
A randomized trial of the intr ...... human immunodeficiency virus.
@nl
prefLabel
A randomized trial of the intr ...... human immunodeficiency virus.
@en
A randomized trial of the intr ...... human immunodeficiency virus.
@nl
P2093
P2860
P50
P1476
A randomized trial of the intr ...... human immunodeficiency virus.
@en
P2093
Benjamin H Chi
Christine Kaseba
Elizabeth M Stringer
Inutu Matongo
Jeffrey S A Stringer
Mulindi Mwanahamuntu
P2860
P304
P356
10.1016/J.AJOG.2007.03.031
P407
P577
2007-08-01T00:00:00Z